ProfoundBio Readies for Next Phase of Growth with Management Team Additions and Advisory Board Appointment
We are thrilled to welcome Erin and Kevin to our leadership team as we plan for this next stage of growth.
- We are thrilled to welcome Erin and Kevin to our leadership team as we plan for this next stage of growth.
- In addition, as chair of our Scientific Advisory Board, Lori brings decades of clinical thought-leadership and strategic product development experience in ADCs.
- We look forward to working alongside them.”
ProfoundBio also announced additional changes to the company's executive team. - Co-founders Tae Han and Xiao Shang will take on the roles of chief strategy officer and head of CMC, respectively.